Lyn Willard

Lyn Willard is a seasoned marketing and bioprocess professional with extensive experience in the biotechnology sector. Currently serving as a Senior Marketing Specialist at Repligen Corporation since January 2021, Lyn previously held a significant role as a Downstream Bioprocess Professional at Alexion, AstraZeneca Rare Disease from October 2001 to February 2022. Earlier in the career, Lyn contributed to Protein Sciences Corporation as a Research Antigen Production Manager from July 1997 to October 2001. Lyn's educational background includes studies at Charter Oak State College and Central Connecticut State University.